Walter H. Moos

5.3k total citations · 1 hit paper
80 papers, 3.9k citations indexed

About

Walter H. Moos is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Walter H. Moos has authored 80 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 19 papers in Organic Chemistry and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Walter H. Moos's work include Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Mitochondrial Function and Pathology (9 papers). Walter H. Moos is often cited by papers focused on Chemical Synthesis and Analysis (12 papers), Receptor Mechanisms and Signaling (9 papers) and Mitochondrial Function and Pathology (9 papers). Walter H. Moos collaborates with scholars based in United States, Canada and Greece. Walter H. Moos's co-authors include Ronald N. Zuckermann, Janice M. Kerr, Stephen B. H. Kent, Simon Ng, Susan M. Miller, Reyna J. Simon, Michael R. Pavia, James A. Bristol, Ronald E. Weishaar and Ila Sircar and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Walter H. Moos

78 papers receiving 3.7k citations

Hit Papers

Efficient method for the preparation of peptoids [oligo(N... 1992 2026 2003 2014 1992 250 500 750 1000

Peers

Walter H. Moos
David A. Price United States
Patrick J. Loll United States
Xiang Li China
Gerd Folkers Switzerland
Roger Freidinger United States
Erin E. Carlson United States
David A. Price United States
Walter H. Moos
Citations per year, relative to Walter H. Moos Walter H. Moos (= 1×) peers David A. Price

Countries citing papers authored by Walter H. Moos

Since Specialization
Citations

This map shows the geographic impact of Walter H. Moos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter H. Moos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter H. Moos more than expected).

Fields of papers citing papers by Walter H. Moos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter H. Moos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter H. Moos. The network helps show where Walter H. Moos may publish in the future.

Co-authorship network of co-authors of Walter H. Moos

This figure shows the co-authorship network connecting the top 25 collaborators of Walter H. Moos. A scholar is included among the top collaborators of Walter H. Moos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter H. Moos. Walter H. Moos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moos, Walter H., Douglas V. Faller, Ioannis P. Glavas, et al.. (2023). Epilepsy: Mitochondrial connections to the ‘Sacred’ disease. Mitochondrion. 72. 84–101. 20 indexed citations
2.
Moos, Walter H., Douglas V. Faller, Ioannis P. Glavas, et al.. (2021). Pathogenic mitochondrial dysfunction and metabolic abnormalities. Biochemical Pharmacology. 193. 114809–114809. 29 indexed citations
3.
Johnson, Deborah L., et al.. (2021). Are in‐person scientific conferences dead or alive?. FASEB BioAdvances. 3(6). 420–427. 11 indexed citations
4.
Moos, Walter H., Douglas V. Faller, Ioannis P. Glavas, et al.. (2019). Epigenetic treatment of dermatologic disorders. Drug Development Research. 80(6). 702–713. 2 indexed citations
5.
Moos, Walter H., Douglas V. Faller, Ioannis P. Glavas, et al.. (2018). A New Approach to Treating Neurodegenerative Otologic Disorders. BioResearch open access. 7(1). 107–115. 9 indexed citations
6.
Kodukula, Krishna, Douglas V. Faller, David N. Harpp, et al.. (2017). Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something. BioResearch open access. 6(1). 123–132. 47 indexed citations
7.
Madrid, Peter B., Sidharth Chopra, Ian D. Manger, et al.. (2013). A Systematic Screen of FDA-Approved Drugs for Inhibitors of Biological Threat Agents. PLoS ONE. 8(4). e60579–e60579. 188 indexed citations
8.
Song, Benben, Amit K. Galande, Krishna Kodukula, Walter H. Moos, & Susan M. Miller. (2011). Evaluation of the pKa values and ionization sequence of bumetanide using 1H and 13C NMR and UV spectroscopy. Drug Development Research. 72(5). 416–426. 5 indexed citations
9.
Moos, Walter H., James A. Dykens, Dana Nohynek, Evelina Rubinchik, & Neil Howell. (2009). Review of the effects of 17α‐estradiol in humans: a less feminizing estrogen with neuroprotective potential. Drug Development Research. 70(1). 1–21. 25 indexed citations
10.
Moos, Walter H., et al.. (2009). Combinatorial chemistry: oh what a decade or two can do. Molecular Diversity. 13(2). 241–245. 29 indexed citations
11.
Dykens, James A., Walter H. Moos, & Neil Howell. (2005). Development of 17α‐Estradiol as a Neuroprotective Therapeutic Agent: Rationale and Results from a Phase I Clinical Study. Annals of the New York Academy of Sciences. 1052(1). 116–135. 60 indexed citations
12.
Ng, Simon, et al.. (1999). Combinatorial discovery process yields antimicrobial peptoids. Bioorganic & Medicinal Chemistry. 7(9). 1781–1785. 47 indexed citations
13.
Miller, Susan M., Reyna J. Simon, Simon Ng, et al.. (1995). Comparison of the proteolytic susceptibilities of homologous L‐amino acid, D‐amino acid, and N‐substituted glycine peptide and peptoid oligomers. Drug Development Research. 35(1). 20–32. 360 indexed citations
14.
Martin, Éric, Jeffrey M. Blaney, Michael A. Siani, et al.. (1995). Measuring Diversity: Experimental Design of Combinatorial Libraries for Drug Discovery. Journal of Medicinal Chemistry. 38(9). 1431–1436. 211 indexed citations
15.
Tecle, Haile, Tara Mirzadegan, Walter H. Moos, et al.. (1993). Synthesis and Sar of bulky 1-azabicyclo[2.2.1]-3-one oximes as muscarinic receptor subtype selective agonists. Life Sciences. 52(5-6). 505–511. 18 indexed citations
16.
Bandoli, Giuliano, et al.. (1991). Conformation of three tetrahydropyridinyl oxime cognition activators. Journal of Chemical Crystallography. 21(4). 419–429. 2 indexed citations
17.
Moos, Walter H., et al.. (1990). Drug discovery technologies. 29 indexed citations
18.
Meltzer, Leonard T., Kevin A. Serpa, & Walter H. Moos. (1989). Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide. Psychopharmacology. 99(1). 103–108. 34 indexed citations
19.
Moos, Walter H., Christine Humblet, Ila Sircar, et al.. (1987). Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity. Journal of Medicinal Chemistry. 30(11). 1963–1972. 63 indexed citations
20.
Bridges, Alexander J., Walter H. Moos, Bharat K. Trivedi, et al.. (1987). N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. Journal of Medicinal Chemistry. 30(10). 1709–1711. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026